Market Insight

Jenscare Scientific has received CE mark approval under the EU Medical Device Regulation (MDR) for its LuX-Valve Plus transvenous tricuspid valve replacement (TTVR) system, expanding treatment options for patients with severe tricuspid regurgitation.
The second-generation device is designed to replac

Leo Cancer Care has raised $65 million in an oversubscribed Series D financing to accelerate the commercialization of its integrated upright cancer care platform across proton therapy, photon therapy, and imaging.
The round was led by Yu Galaxy, with participation from new investor Eventide Asset Man

Nyra Medical has enrolled the first patient in its ENHANCE early feasibility study evaluating the investigational CARLEN transcatheter cardiac leaflet enhancer for patients with functional mitral regurgitation (FMR).
CARLEN is a single-leaflet implant designed to augment the native mitral valve, rest

AtaCor Medical has enrolled the first patient in the ALARION-EV pivotal trial evaluating its next-generation extravascular implantable cardioverter-defibrillator (EV-ICD) system, developed in partnership with Abbott.
The investigational system combines AtaCor's Atala parasternal lead with Abbott's EV

Medicaroid has received CE-MDR approval for its Hinotori surgical robot system, enabling the company to expand its robotic-assisted surgery platform into the European market.
Hinotori is designed to support minimally invasive surgery with eight-axis robotic arms that replicate surgeons' hand movement

xDot Medical has received FDA investigational device exemption (IDE) approval to begin a pivotal clinical trial of its Access Management System (AMS) for closing large-bore femoral arterial and venous access sites following catheter-based procedures.
The study will enroll 266 patients, including roll

Movmedix has received FDA 510(k) clearance for its third-generation LARS ACJ synthetic ligament implant, marking the company's first U.S. regulatory approval and enabling the launch of the shoulder repair system in the United States.
The implant is designed to treat acromioclavicular (ACJ) joint inju

Neo Medical has launched its Neo Instant MIS Access platform in the United States, expanding its minimally invasive spine surgery offering for thoracic, lumbar, and sacral procedures.
The system is designed to simplify posterior MIS workflows by removing reliance on capital equipment, reusable instru

Reflow Medical has enrolled the first patient in the DEEPER CHALLENGE study evaluating its Spur Peripheral Retrievable Scaffold System for below-the-knee treatment in patients with chronic limb-threatening ischemia (CLTI).
The single-center study at the Medical University of Graz will enroll up to 40